The Administrative Core will provide scientific leadership to the ADRC, review and set priorities for general and specific research directions, and ensure that resources, infrastructure and feasibility are maintained to support ongoing and new research initiatives. The ADRC Director, Associate Director and Administrator will oversee the Cores and Projects, and the clinical sites in La Jolla and Chula Vista. The Core will promote interactions with researchers at UCSD, and with other institutes in San Diego, to foster ongoing and new research initiatives. Interactions with community organizations, including the Alzheimer's Association, and with lay representatives will enhance outreach efforts. An External Scientific Advisory Committee will visit and review the ADRC once per year and will review proposed Pilot Projects. Fiscal management of the Center will facilitate its smooth operation. The Administrative Core will also coordinate interactions with philanthropic donors to support Center activities, together with the UCSD Office of Planned Giving. ADRC staff will be expected to be knowledgeable about and compliant with regulations regarding human subjects, animal welfare, scientific integrity, data security, data and sample sharing, and financial policy, and will follow HIPAA-compliant procedures. The Administrative Core will interact with other AD Centers, the National Alzheimer's Coordinating Center and other researchers to develop and support research projects that cut across ADCs. Procedures will be maintained to ensure timely transmission of ADRC data sets, including the UDS clinical and neuropathology data, to the NACC. ADRC leaders will be responsible for liaison with NIA and NACC, and they, as well as representatives of Cores, will attend semi-annual meetings of the Centers. The Core will ensure that the ADRCC maintains an up to date website, which will assist with other efforts to ensure that ADRC research findings, resources and opportunities are publicized.

Public Health Relevance

(Seeinstructions): AD affects millions of Americans with its risk growing exponentially with age. The AD Centers Program fosters research related to AD and non-AD dementias. The ADRC will enhance the performance of innovative research on AD and related topics, including research that may lead to potential disease modifying therapies or behavioral treatments. It will provide an environment and core resources to enhance research, foster professional and community training, and coordinate interdisciplinary research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005131-30
Application #
8449625
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
30
Fiscal Year
2013
Total Cost
$628,934
Indirect Cost
$82,225
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Ronquillo, Jay Geronimo; Baer, Merritt Rachel; Lester, William T (2016) Sex-specific patterns and differences in dementia and Alzheimer's disease using informatics approaches. J Women Aging 28:403-11
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-20
Ringman, John M; Monsell, Sarah; Ng, Denise W et al. (2016) Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. J Neuropathol Exp Neurol 75:284-90
Besser, Lilah M; Alosco, Michael L; Ramirez Gomez, Liliana et al. (2016) Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition. J Neuropathol Exp Neurol 75:955-962
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2016) Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development. Arch Gerontol Geriatr 65:231-8
de Wilde, Martijn C; Overk, Cassia R; Sijben, John W et al. (2016) Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement 12:633-44
John, Samantha E; Gurnani, Ashita S; Bussell, Cara et al. (2016) The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set. Neuropsychology 30:946-960
Bonham, Luke W; Geier, Ethan G; Fan, Chun C et al. (2016) Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease. Ann Clin Transl Neurol 3:668-77
Ting, Simon Kang Seng; Hao, Ying; Chia, Pei Shi et al. (2016) Clinicopathological correlation of psychosis and brain vascular changes in Alzheimer's disease. Sci Rep 6:20858
Valera, Elvira; Masliah, Eliezer (2016) Combination therapies: The next logical Step for the treatment of synucleinopathies? Mov Disord 31:225-34

Showing the most recent 10 out of 711 publications